Eli Lilly to Invest $1 Billion in India to Boost Contract Manufacturing and Global Medicine Supply
Updated: Oct 07, 2025 05:24:39pm
New Delhi, Oct 7 (KNN) Eli Lilly, the U.S.-based pharmaceutical giant, has announced plans to invest over $1 billion in India over the coming years.
This move aims to strengthen contract manufacturing and supply chain capabilities through partnerships with local drugmakers.
A major part of this investment will be the establishment of a new manufacturing and global medicine supply hub in Hyderabad. The facility will serve as a central point to oversee and enhance Lilly’s contract manufacturing network across India, supporting the production of essential medicines for various conditions.
Patrik Jonsson, President of Lilly International, said the initiative highlights the company’s commitment to expanding global manufacturing capacity and ensuring medicines are widely available.
The Hyderabad facility is expected to support the production of treatments for diabetes, obesity, Alzheimer’s disease, cancer, and autoimmune disorders, leveraging India’s skilled workforce.
Recruitment for the new facility will begin immediately, with positions open for engineers, chemists, analytical scientists, quality control and assurance professionals, and management staff.
This expansion follows the opening of a global capability center (GCC) in Hyderabad just a year ago, demonstrating Lilly’s growing presence in India.
Although Eli Lilly does not currently operate its own manufacturing facility in India, the company has committed $55 billion globally to build, expand, and acquire facilities.
The investment reflects a strategic focus on strengthening manufacturing and supply chains to meet rising global demand.
India, known for its robust pharmaceutical sector and skilled workforce, continues to attract major global pharma investments. Eli Lilly’s $1 billion plan is part of a broader trend of multinational drugmakers boosting production capabilities in the country to ensure timely access to critical medicines worldwide.
(KNN Bureau)





Loading...
